Richard Law
Analyst, Goldman Sachs
Analyst — Goldman Sachs
Earnings-call appearances
-
Second Quarter 2026 Earnings Call2026-08-11
Mineralys Therapeutics, Inc. (MLYS)
-
Bicara Therapeutics Inc. Q1 FY2026 Earnings Call2026-05-11
Bicara Therapeutics Inc. (BCAX)
-
Crinetics Pharmaceuticals, Inc. Q1 FY2026 Earnings Call2026-05-07
Crinetics Pharmaceuticals, Inc. (CRNX)
-
Mineralys Therapeutics, Inc. Q1 FY2026 Earnings Call2026-05-06
Mineralys Therapeutics, Inc. (MLYS)
-
Arcus Biosciences, Inc. Q1 FY2026 Earnings Call2026-05-05
Arcus Biosciences, Inc. (RCUS)
-
Mineralys Therapeutics, Inc. Q1 FY2025 Earnings Call2025-05-12
Mineralys Therapeutics, Inc. (MLYS)
-
Silence Therapeutics plc Q4 FY2024 Earnings Call2025-02-27
Silence Therapeutics plc (SLN)
-
Mineralys Therapeutics, Inc. Q4 FY2024 Earnings Call2025-02-12
Mineralys Therapeutics, Inc. (MLYS)
-
Mineralys Therapeutics, Inc. Q3 FY2024 Earnings Call2024-11-12
Mineralys Therapeutics, Inc. (MLYS)
-
Mineralys Therapeutics, Inc. Q2 FY2024 Earnings Call2024-08-13
Mineralys Therapeutics, Inc. (MLYS)
-
Intellia Therapeutics, Inc. Q2 FY2023 Earnings Call2023-08-03
Intellia Therapeutics, Inc. (NTLA)
-
Intellia Therapeutics, Inc. Q1 FY2023 Earnings Call2023-05-04
Intellia Therapeutics, Inc. (NTLA)
-
Editas Medicine, Inc. Q4 FY2022 Earnings Call2023-02-22
Editas Medicine, Inc. (EDIT)
-
Intellia Therapeutics, Inc. Q3 FY2022 Earnings Call2022-11-03
Intellia Therapeutics, Inc. (NTLA)
-
Kymera Therapeutics, Inc. Q2 FY2022 Earnings Call2022-08-09
Kymera Therapeutics, Inc. (KYMR)
-
Intellia Therapeutics, Inc. Q2 FY2022 Earnings Call2022-08-04
Intellia Therapeutics, Inc. (NTLA)